Department of Pharmacology and Toxicology, Defence Research and Development Establishment, Gwalior, India.
Oxid Med Cell Longev. 2009 Sep-Oct;2(4):191-206. doi: 10.4161/oxim.2.4.9112.
Oxidative stress contributes to the pathophysiology of exposure to heavy metals/metalloid. Beneficial renal effects of some medications, such as chelation therapy depend at least partially on the ability to alleviate oxidative stress. The administration of various natural or synthetic antioxidants has been shown to be of benefit in the prevention and attenuation of metal induced biochemical alterations. These include vitamins, N-acetylcysteine, alpha-lipoic acid, melatonin, dietary flavonoids and many others. Human studies are limited in this regard. Under certain conditions, surprisingly, the antioxidant supplements may exhibit pro-oxidant properties and even worsen metal induced toxic damage. To date, the evidence is insufficient to recommend antioxidant supplements in subject with exposure to metals. Prospective, controlled clinical trials on safety and effectiveness of different therapeutic antioxidant strategies either individually or in combination with chelating agent are indispensable. The present review focuses on structural, chemical and biological aspects of antioxidants particularly related to their chelating properties.
氧化应激是暴露于重金属/类金属的病理生理学的一个因素。一些药物(如螯合疗法)对肾脏有益的作用至少部分依赖于减轻氧化应激的能力。已证明各种天然或合成抗氧化剂的给药在预防和减轻金属诱导的生化改变方面是有益的。这些包括维生素、N-乙酰半胱氨酸、α-硫辛酸、褪黑素、膳食类黄酮和许多其他物质。在这方面,人体研究是有限的。在某些情况下,令人惊讶的是,抗氧化补充剂可能表现出促氧化特性,甚至使金属诱导的毒性损伤恶化。迄今为止,没有足够的证据推荐抗氧化补充剂用于接触金属的人群。关于不同治疗性抗氧化策略的安全性和有效性的前瞻性、对照临床试验,无论是单独使用还是与螯合剂联合使用,都是必不可少的。本综述重点介绍了抗氧化剂的结构、化学和生物学方面,特别是与它们的螯合特性有关的方面。